Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1507245439;45440;45441 chr2:178621610;178621609;178621608chr2:179486337;179486336;179486335
N2AB1343140516;40517;40518 chr2:178621610;178621609;178621608chr2:179486337;179486336;179486335
N2A1250437735;37736;37737 chr2:178621610;178621609;178621608chr2:179486337;179486336;179486335
N2B600718244;18245;18246 chr2:178621610;178621609;178621608chr2:179486337;179486336;179486335
Novex-1613218619;18620;18621 chr2:178621610;178621609;178621608chr2:179486337;179486336;179486335
Novex-2619918820;18821;18822 chr2:178621610;178621609;178621608chr2:179486337;179486336;179486335
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-102
  • Domain position: 42
  • Structural Position: 70
  • Q(SASA): 0.5217
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs963923376 0.568 0.939 N 0.505 0.366 0.426551566703 gnomAD-2.1.1 8.08E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 8.95E-06 0
E/K rs963923376 0.568 0.939 N 0.505 0.366 0.426551566703 gnomAD-4.0.0 2.73863E-06 None None None None N None 0 0 None 0 0 None 0 0 8.99905E-07 2.31932E-05 1.65837E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.158 likely_benign 0.171 benign -0.327 Destabilizing 0.939 D 0.525 neutral N 0.478445226 None None N
E/C 0.8955 likely_pathogenic 0.9157 pathogenic -0.094 Destabilizing 0.999 D 0.623 neutral None None None None N
E/D 0.1925 likely_benign 0.2006 benign -0.425 Destabilizing 0.02 N 0.22 neutral N 0.446255996 None None N
E/F 0.8565 likely_pathogenic 0.8647 pathogenic -0.105 Destabilizing 0.999 D 0.588 neutral None None None None N
E/G 0.1574 likely_benign 0.1607 benign -0.537 Destabilizing 0.939 D 0.462 neutral N 0.511406037 None None N
E/H 0.5861 likely_pathogenic 0.5976 pathogenic 0.183 Stabilizing 0.999 D 0.533 neutral None None None None N
E/I 0.5537 ambiguous 0.5486 ambiguous 0.195 Stabilizing 0.993 D 0.617 neutral None None None None N
E/K 0.1712 likely_benign 0.1629 benign 0.421 Stabilizing 0.939 D 0.505 neutral N 0.51191043 None None N
E/L 0.563 ambiguous 0.5704 pathogenic 0.195 Stabilizing 0.993 D 0.609 neutral None None None None N
E/M 0.6205 likely_pathogenic 0.6276 pathogenic 0.196 Stabilizing 0.999 D 0.53 neutral None None None None N
E/N 0.3371 likely_benign 0.3545 ambiguous -0.087 Destabilizing 0.973 D 0.498 neutral None None None None N
E/P 0.334 likely_benign 0.4055 ambiguous 0.041 Stabilizing 0.993 D 0.569 neutral None None None None N
E/Q 0.1599 likely_benign 0.1625 benign -0.021 Destabilizing 0.991 D 0.489 neutral N 0.512264129 None None N
E/R 0.2832 likely_benign 0.2879 benign 0.645 Stabilizing 0.993 D 0.548 neutral None None None None N
E/S 0.217 likely_benign 0.2402 benign -0.19 Destabilizing 0.953 D 0.49 neutral None None None None N
E/T 0.2887 likely_benign 0.2886 benign -0.008 Destabilizing 0.986 D 0.518 neutral None None None None N
E/V 0.3393 likely_benign 0.3397 benign 0.041 Stabilizing 0.991 D 0.545 neutral N 0.516741885 None None N
E/W 0.9413 likely_pathogenic 0.9458 pathogenic 0.068 Stabilizing 0.999 D 0.629 neutral None None None None N
E/Y 0.7457 likely_pathogenic 0.7607 pathogenic 0.149 Stabilizing 0.999 D 0.535 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.